VO659-CT01
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Phase 1/2 study testing VO659 to assess its safety and tolerability in people with Huntington's disease.
RecruitingPhase 1 / Phase 2DrugClinicalTrials.govTreatment trial
Recruiting in: Angers, Bochum, Bonn +11 more (Denmark, France, Germany +3 more)
Sponsor: Vico Therapeutics B. V.
Preparing a short plain-English summary.